Thyrotoxic, hypokalaemic periodic paralysis: Polynesians, an ethnic group at risk

Internal Medicine Journal

Volumn 37, Issue 5, 2007, Pages 303-307

  Elston, M S ^a   Orr Walker, B J ^a   Dissanayake, A M ^a   Conaglen, J V ^b  

^a MIDDLEMORE HOSPITAL   (New Zealand)

^b WAIKATO HOSPITAL   (New Zealand)

Author keywords

Hypokalaemia; Periodic paralysis; Thyrotoxicosis

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; ASIAN; CLINICAL ARTICLE; CONTROLLED STUDY; ETHNIC DIFFERENCE; ETHNIC GROUP; FEMALE; HIGH RISK POPULATION; HUMAN; MALE; MAORI; MUSCLE WEAKNESS; NEW ZEALAND; PACIFIC ISLANDER; PERIODIC PARALYSIS; PRIORITY JOURNAL; RETROSPECTIVE STUDY; THYROTOXIC HYPOKALEMIC PERIODIC PARALYSIS; THYROTOXICOSIS;

ADULT; FEMALE; HUMANS; HYPOKALEMIC PERIODIC PARALYSIS; MALE; MIDDLE AGED; NEW ZEALAND; POLYNESIA; RETROSPECTIVE STUDIES; THYROTOXICOSIS;

EID: 34248327216     PISSN: 14440903     EISSN: 14455994     Source Type: Journal    
DOI: 10.1111/j.1445-5994.2007.01313.x     Document Type: Article

References (31)

1. Chen YC, Fang JT, Chang CT, Chou HH. Thyrotoxic periodic paralysis in a patient abusing thyroxine for weight reduction. Ren Fail 2001 23: 139 42.
2. McFadzean AJ, Yeung R. Periodic paralysis complicating thyrotoxicosis in Chinese. Br Med J 1967 1: 451 5.
3. Conway MJ, Seibel JA, Eaton P. Thyrotoxicosis and periodic paralysis: improvement with beta blockade. Ann Intern Med 1974 81: 332 6.
4. Ober KP. Thyrotoxic periodic paralysis in the United States. Report of 7 cases and review of the literature. Medicine 1992 71: 109 20.
5. Ko GT, Chow CC, Yeung VT, Chan HH, Li JK, Cockram CS. Thyrotoxic periodic paralysis in a Chinese population. QJM 1996 89: 463 8.
6. Lin SH. Thyrotoxic periodic paralysis. Mayo Clin Proc 2005 80: 99 105.
7. Tran HA, Kay SE, Kende M, Doery JC, Colman PG, Read A. Thyrotoxic, hypokalaemic periodic paralysis in Australasian men. Intern Med J 2003 33: 91 4.
8. Kelley DE, Gharib H, Kennedy FP, Duda RJ Jr., McManis PG. Thyrotoxic periodic paralysis. Report of 10 cases and review of electromyographic findings. Arch Intern Med 1989 149: 2597 600.
9. Chen L, Lang D, Ran XW, Joncourt F, Gallati S, Burgunder JM. Clinical and molecular analysis of Chinese patients with thyrotoxic periodic paralysis. Eur Neurol 2003 49: 227 30.
10. Lu KC, Hsu YJ, Chiu JS, Hsu YD, Lin SH. Effects of potassium supplementation on the recovery of thyrotoxic periodic paralysis. Am J Emerg Med 2004 22: 544 7.
11. Lin SH, Lin YF, Chen DT, Chu P, Hsu CW, Halperin ML. Laboratory tests to determine the cause of hypokalemia and paralysis. Arch Intern Med 2004 164: 1561 6.
12. Fisher J. Thyrotoxic periodic paralysis with ventricular fibrillation. Arch Intern Med 1982 142: 1362 4.
13. Boccalandro C, Lopez L, Boccalandro F, Lavis V. Electrocardiographic changes in thyrotoxic periodic paralysis. Am J Cardiol 2003 91: 775 7.
14. Tassone H, Moulin A, Henderson SO. The pitfalls of potassium replacement in thyrotoxic periodic paralysis: a case report and review of the literature. J Emerg Med 2004 26: 157 61.
15. Kung AW, Lau KS, Fong GC, Chan V. Association of novel single nucleotide polymorphisms in the calcium channel alpha 1 subunit gene (Ca(v)1.1) and thyrotoxic periodic paralysis. J Clin Endocrinol Metab 2004 89: 1340 5.
16. Dias Da Silva MR, Cerutti JM, Arnaldi LA, Maciel RM. A mutation in the KCNE3 potassium channel gene is associated with susceptibility to thyrotoxic hypokalemic periodic paralysis. J Clin Endocrinol Metab 2002 87: 4881 4.
17. Dias da Silva MR, Cerutti JM, Tengan CH, Furuzawa GK, Vieira TC, Gabbai AA et al. Mutations linked to familial hypokalaemic periodic paralysis in the calcium channel alpha1 subunit gene (Cav1.1) are not associated with thyrotoxic hypokalaemic periodic paralysis. Clin Endocrinol 2002 56: 367 75.
18. Chan A, Shinde R, Chow CC, Cockram CS, Swaminathan R. Hyperinsulinaemia and Na+, K(+)-ATPase activity in thyrotoxic periodic paralysis. Clin Endocrinol 1994 41: 213 16.
19. Kung AW, Lau KS, Cheung WM, Chan V. Thyrotoxic periodic paralysis and polymorphisms of sodium-potassium ATPase genes. Clin Endocrinol 2006 64: 158 61.
20. Lin SH, Lin YF. Propranolol rapidly reverses paralysis, hypokalemia, and hypophosphatemia in thyrotoxic periodic paralysis. Am J Kidney Dis 2001 37: 620 3.
21. Wild E. Thyrotoxic periodic paralysis in a Maori patient. NZ Med J 2004 117: U1204
22. Carroll DG. Hypokalaemic periodic paralysis in a thyrotoxic Polynesian. Postgrad Med J 1994 70: 39 40.
23. Ober KP, Hennessy JF. Jodbasedow and thyrotoxic periodic paralysis. Arch Intern Med 1981 141: 1225 7.
24. Zumo LA, Terzian C, Brannan T. Thyrotoxic hypokalemic periodic paralysis in a Hispanic male. J Natl Med Assoc 2002 94: 383 6.
25. Kilpatrick RE, Seiler-Smith S, Levine SN. Thyrotoxic hypokalemic periodic paralysis: report of four cases in black American males. Thyroid 1994 4: 441 5.
26. Iheonunekwu NC, Ibrahim TM, Davies D, Pickering K. Thyrotoxic hypokalaemic paralysis in a pregnant Afro-Caribbean woman. A case report and review of the literature. West Indian Med J 2004 53: 47 9.
27. Underhill PA, Passarino G, Lin AA, Marzuki S, Defner PJ, Cavalli-Sforza LL et al. Maori origins, Y-chromosome haplotypes and implications for human history in the Pacific. Hum Mutat 2001 17: 271 80.
28. Huang TY, Lin SH. Thyrotoxic hypokalemic periodic paralysis reversed by propranolol without rebound hyperkalemia. Ann Emerg Med 2001 37: 415 16.
29. Shayne P, Hart A. Thyrotoxic periodic paralysis terminated with intravenous propranolol. Ann Emerg Med 1994 24: 736 40.
30. Birkhahn RH, Gaeta TJ, Melniker L. Thyrotoxic periodic paralysis and intravenous propranolol in the emergency setting. J Emerg Med 2000 18: 199 202.
31. Lin SH, Lin YF, Halperin ML. Hypokalaemia and paralysis. QJM 2001 94: 133 9.